
    
      the role of metformin when combined with traditional metastatic breast cancer treatment in
      non-diabetic patients compared to diabetic patients who are not using metformin. In this
      randomized control study, there will be a demonstration either it is effective to suppress
      tumor burden or not through normal screening for tumor.
    
  